In this review, we discuss the current understanding of ovarian cancer metastasis mechanisms, summarize recent findings that obesity contributes to cancer progression with a focus on the role of lipid regulatory protein SREBP1 in regulating cancer progression and metastasis, and discuss potential therapeutic targets in obese cancer patients. Here, SREBF1 is linked to obesity due to melanocortin 4 receptor deficiency.